Intranasal Insulin Treatment May Enhance Cognition in Mild Cognitive Impairment or Alzheimer's, Meta-Analysis Shows

PLOS

Intranasal insulin treatment might boost cognition in people with mild cognitive impairment or Alzheimer's Disease, according to meta-analysis of 29 studies across multiple disorders

/Public Release. This material from the originating organization/author(s) might be of the point-in-time nature, and edited for clarity, style and length. Mirage.News does not take institutional positions or sides, and all views, positions, and conclusions expressed herein are solely those of the author(s).View in full here.